Literature DB >> 10561636

Jelly beans as an alternative to a fifty-gram glucose beverage for gestational diabetes screening.

M E Lamar1, T J Kuehl, A T Cooney, L J Gayle, S Holleman, S R Allen.   

Abstract

OBJECTIVE: This study tested the hypothesis that a standardized dose of jelly beans could be used as an alternative sugar source to the 50-g glucose beverage to screen for gestational diabetes mellitus. STUDY
DESIGN: One hundred sixty pregnant women at 24 to 28 weeks' gestation were recruited for a prospective study to compare 2 sugar sources for serum glucose response, side effects, preference, and ability to detect gestational diabetes mellitus. Patients were randomly assigned to consume 50-g glucose beverage or 28 jelly beans (50 g simple carbohydrate). Serum glucose values were determined 1 hour later. The test was later repeated with the other sugar source. Finally, a 100-g 3-hour oral glucose tolerance test was performed. Participants completed a questionnaire recording subjective outcome variables. American Diabetes Association criteria were used to interpret all test results.
RESULTS: Among 136 participants completing the study no significant differences were found between 1-hour serum glucose values (116.5 +/- 27 mg/dL with 50-g glucose beverage, 116.9 +/- 23.6 mg/dL with jelly beans; P =.84), frequency of discrepant results (P =.47), sensitivity, specificity, or predictive value. Jelly beans yielded fewer side effects (38% with 50-g glucose beverage, 20% with jelly beans; P <.001) and were preferred by 76% of participants (P <.001). Five cases (3.7% incidence) of gestational diabetes mellitus were diagnosed, 3 with 50-g glucose beverage alone, 1 with jelly beans alone, and 1 with both sugar sources.
CONCLUSIONS: Jelly beans may be used as an alternative to the 50-g glucose beverage as a sugar source for gestational diabetes mellitus screening. The 2 sources provoke similar serum glucose responses. Patients report fewer side effects after a jelly bean challenge than after a 50-g glucose beverage challenge.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10561636     DOI: 10.1016/s0002-9378(99)70099-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health.

Authors:  Joanna Tieu; Andrew J McPhee; Caroline A Crowther; Philippa Middleton; Emily Shepherd
Journal:  Cochrane Database Syst Rev       Date:  2017-08-03

2.  Lipid profile in relation to anthropometric indices and insulin resistance in overweight women with polycystic ovary syndrome.

Authors:  Maryam Saghafi-Asl; Saeed Pirouzpanah; Mehranghiz Ebrahimi-Mameghani; Mohammad Asghari-Jafarabadi; Soudabeh Aliashrafi; Bita Sadein
Journal:  Health Promot Perspect       Date:  2013-12-31

3.  Evaluation of a novel supplement to reduce blood glucose through the use of a modified oral glucose tolerance test.

Authors:  Adam J Smith; Brian Giunta; R Douglas Shytle; James M Blum
Journal:  Am J Transl Res       Date:  2011-02-16       Impact factor: 4.060

4.  Noninvasive in vivo glucose sensing on human subjects using mid-infrared light.

Authors:  Sabbir Liakat; Kevin A Bors; Laura Xu; Callie M Woods; Jessica Doyle; Claire F Gmachl
Journal:  Biomed Opt Express       Date:  2014-06-23       Impact factor: 3.732

Review 5.  Different strategies for diagnosing gestational diabetes to improve maternal and infant health.

Authors:  Diane Farrar; Lelia Duley; Therese Dowswell; Debbie A Lawlor
Journal:  Cochrane Database Syst Rev       Date:  2017-08-23

Review 6.  Screening and subsequent management for gestational diabetes for improving maternal and infant health.

Authors:  Joanna Tieu; Philippa Middleton; Andrew J McPhee; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

7.  Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.

Authors:  Dale William Stovall; Amelia Purser Bailey; Lisa M Pastore
Journal:  J Womens Health (Larchmt)       Date:  2010-12-31       Impact factor: 2.681

8.  Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome.

Authors:  Mehranghiz Ebrahimi-Mamaghani; Maryam Saghafi-Asl; Saeed Pirouzpanah; Akbar Aliasgharzadeh; Soudabeh Aliashrafi; Niloufar Rezayi; Mahzad Mehrzad-Sadaghiani
Journal:  J Health Popul Nutr       Date:  2015-03       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.